International Stem Cell Corporation
ISCO
$0.11
-$0.001-0.90%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 16.64% | 2.38% | 3.25% | -5.02% | -4.78% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.64% | 2.38% | 3.25% | -5.02% | -4.78% |
| Cost of Revenue | 18.33% | 5.30% | 2.41% | -3.68% | -2.69% |
| Gross Profit | 15.47% | 0.31% | 3.85% | -5.95% | -6.17% |
| SG&A Expenses | -0.55% | 8.97% | 7.24% | 8.76% | 5.80% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.29% | 6.62% | 5.11% | 2.64% | 1.06% |
| Operating Income | 89.74% | -205.06% | -44.36% | -309.22% | -262.30% |
| Income Before Tax | -59.54% | -293.71% | -595.65% | 12.64% | 60.42% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -59.54% | -293.71% | -595.65% | 12.64% | 60.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -59.54% | -293.71% | -595.65% | 12.64% | 60.42% |
| EBIT | 89.74% | -205.06% | -44.36% | -309.22% | -262.30% |
| EBITDA | 129.42% | -1,815.00% | -103.43% | -9,400.00% | -1,440.00% |
| EPS Basic | -27.20% | -593.20% | -521.19% | -9.46% | 36.80% |
| Normalized Basic EPS | 73.75% | -116.33% | -29.93% | -172.76% | -139.77% |
| EPS Diluted | -39.85% | -615.65% | -549.15% | -16.89% | 36.80% |
| Normalized Diluted EPS | 73.75% | -116.33% | -29.93% | -172.76% | -139.77% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |